Journal of the National Cancer Institute
-
J. Natl. Cancer Inst. · Jul 2017
Multicenter StudyShared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
We previously derived and validated a bronchial epithelial gene expression biomarker to detect lung cancer in current and former smokers. Given that bronchial and nasal epithelial gene expression are similarly altered by cigarette smoke exposure, we sought to determine if cancer-associated gene expression might also be detectable in the more readily accessible nasal epithelium. ⋯ These results support that the airway epithelial field of lung cancer-associated injury in ever smokers extends to the nose and demonstrates the potential of using nasal gene expression as a noninvasive biomarker for lung cancer detection.
-
J. Natl. Cancer Inst. · May 2017
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
Recent studies have suggested associations between statins and enhanced survival among patients with pancreatic ductal adenocarcinoma (PDAC). However, the relationship between statins, cholesterol, and survival remains unclear. ⋯ Statin use rather than cholesterol level was associated with lower mortality risk in patients with pancreatic cancer. Statins appear to improve survival through a lipid-independent mechanism.
-
J. Natl. Cancer Inst. · Mar 2017
Review Meta AnalysisVitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis.
Vitamin B6 is involved in many biochemical reactions and might play a role in carcinogenesis. We summarized the evidence linking vitamin B6 to cancer risk. ⋯ Epidemiological evidence supports the potential of vitamin B6 as a cancer risk reduction agent and the role of PLP as a cancer screening biomarker, especially for gastrointestinal tumors. However, inconsistent findings from total intake and intervention studies suggest that vitamin B6 might also be an indicator of other dietary protective micronutrients.
-
J. Natl. Cancer Inst. · Feb 2017
Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
There is no model to estimate absolute invasive breast cancer risk for Hispanic women. ⋯ The HRM is the first absolute risk model that is based entirely on data specific to Hispanic women by nativity. Further studies in Hispanic women are warranted to evaluate its validity.